An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance.

Saved in:
Bibliographic Details
Title: An Immunomodulating Peptide with Potential to Promote Anticancer Immunity Without Compromising Immune Tolerance.
Authors: Agrez M; InterK Peptide Therapeutics Limited, Sydney, NSW 2113, Australia., Chandler C; Auspep Pty Limited, Melbourne, VIC 3043, Australia., Johnson AL; Inotiv Inc., Boulder, CO 80301, USA., Sorensen M; Inotiv Inc., Boulder, CO 80301, USA., Cho K; Inotiv Inc., Boulder, CO 80301, USA., Parker S; InterK Peptide Therapeutics Limited, Sydney, NSW 2113, Australia., Blyth B; Models of Cancer Translational Research Centre, Research Division, Peter MacCallum Cancer Centre, 305 Grattan St., Melbourne, VIC 3000, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC 3010, Australia., Turner D; Concept Life Sciences, Edinburgh EH16 4UX, UK., Rzepecka J; Concept Life Sciences, Edinburgh EH16 4UX, UK., Knox G; Concept Life Sciences, Edinburgh EH16 4UX, UK., Nika A; Concept Life Sciences, Edinburgh EH16 4UX, UK., Hall AM; Concept Life Sciences, Edinburgh EH16 4UX, UK., Gooding H; Concept Life Sciences, Edinburgh EH16 4UX, UK., Gallagher L; Concept Life Sciences, Edinburgh EH16 4UX, UK.
Source: Biomedicines [Biomedicines] 2025 Aug 05; Vol. 13 (8). Date of Electronic Publication: 2025 Aug 05.
Publication Type: Journal Article
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2227-9059
DOI:10.3390/biomedicines13081908